We have members from multiple industries as network members and this membership is increasingly growing.  For example, Artinis and Siemens Gowerlabs, Shimadzu, Noldus, Roche & Tobii, Hyperfine.

These members are critical to the discussions between academic, industry, and government representatives to develop a long-term strategy to sustain the infrastructure built by this network, after completion of the UKRI grant, and to shorten the time between neurotech development for pediatric populations and their implementation in the health care system.